T he hallmark of adaptive immunity in advanced vertebrates is the existence of lymphocytes, which induce and regulate immune responses. When activated by pathogens in a specific cytokine environment, naive CD4 1 T cells differentiate into different subsets with distinct effector functions aimed at orchestrating and mobilizing other cell types to effectively clear invading pathogens. Based on cytokine phenotypes, initially the existence of two distinct effector T H subsets was proposed: T H 1 and T H 2 (ref. IL-17 is a phylogenetically old cytokine that is also detected in non-mammalian vertebrates 5 . In addition to IL-17A, T H 17 cells co-produce IL-17F 3, 6 . IL-17A and IL-17F have similar functions. They induce the production of proinflammatory cytokines, chemokines and metalloproteinases from various tissues and cell types (Box 1). As a result, they recruit neutrophils to tissues.
Although there is often a coordinated expression of IL-17A and IL-17F in T H 17 cells and other cell types, it is now clear that there are T H cells expressing only IL-17A, IL-17F or an IL-17A-IL-17F heterodimer 7, 8 . In addition to IL-17A and IL-17F, T H 17 cells produce other effector cytokines, namely IL-21 and IL-22 (refs 6, 9-12) . Neither IL-21 nor IL-22 are T H 17-exclusive cytokines, but are preferentially expressed in T H 17 cells.
Recent work from our group and others showed that IL-21, a member of the IL-2 family of cytokines, is produced in large amounts by T H 17 cells and ICOS
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1 T follicular helper cells 13 . These T follicular helper cells home to the B-cell areas of secondary lymphoid tissue and provide cognate help to B cells. However, it remains to be seen whether T follicular helper cells could represent activated or memory T H 17 cells that help B cells in secondary or tertiary lymphoid organs. IL-22 is a member of the IL-10 family of cytokines, produced by activated T cells and natural killer cells. It mediates its effects through a receptor complex composed of the IL-10R2 and the IL-22R chains. Interestingly, high concentrations of transforming growth factor-b (TGF-b) can inhibit IL-6-induced IL-22 expression 9 . Furthermore, whereas the combination of TGF-b plus IL-6 induces large quantities of IL-17A and IL-17F by T H 17 cells, the secretion of large amounts of IL-22 by T H 17 cells requires the addition of IL-23 in vitro 6, 9 . This suggests that IL-22 could represent an end point effector cytokine produced by terminally differentiated T H 17 cells.
An important role for T H 17 cells in host defence
So far it is unclear which class of pathogens preferentially induces a T H 17 response because pathogens as diverse as the Gram-positive Propionibacterium acnes, the Gram-negative Citrobacter rodentium, Klebsiella pneumoniae, Bacteroides spp. and Borrelia spp., the acid-fast Mycobacterium tuberculosis, and fungi such as Candida albicans can all trigger a substantial T H 17 response [14] [15] [16] [17] [18] [19] . The fungal-cell-wall-derived product zymosan or other dectin-1 ligands as well as muramyldipeptide (a derivative of bacterial peptidoglycan) are able to promote IL-17 production in T cells 20 . 18 .
T H 17 cells in autoimmune diseases
It is widely conceived that organ-specific autoimmune diseases are the result of dysregulated autoantigen-specific T H 1 responses. In many animal models of human autoimmune diseases, T H 1 cells have been shown to be pathogenic 21 . However, the concept that autoimmune diseases were exclusively mediated by T H 1 cells has been challenged, and the idea that T H 17 cells are an important part of the autoimmune reaction has emerged in light of the following observations: first, mice deficient for the T H 1 effector cytokine IFN-c develop enhanced experimental autoimmune encephalomyelitis (EAE) 22 ; second, deficiency in the IL-12p35 subunit (specific for IL-12) does not alter the progression of EAE, but deficiency in either p40 or p19, which form IL-23, results in a decreased number of T H 17 cells and protection from EAE and collagen-induced arthritis 23, 24 ; third, the transfer of myelin-reactive IL-17-producing T cells expanded with IL-23 in vitro induces severe EAE 3 ; and fourth, IL-17 has profound pro-inflammatory effects and induces tissue damage during the course of various autoimmune diseases. Indeed, IL-17 can directly or indirectly promote cartilage and bone destruction 25 . Conversely, IL-17-deficient mice develop attenuated collagen-induced arthritis 26 and EAE 27 . Increased levels of IL-17 have been observed in patients with rheumatoid arthritis 28 , multiple sclerosis 29 , inflammatory bowel disease 30 and psoriasis 31 . Furthermore, IL-22 produced by T H 17 cells mediates IL-23-induced acanthosis and dermal inflammation 9 . In addition, IL-22, similarly to IL-17, can disrupt tight junctions between endothelial cells of the blood-brain barrier 32 . These data indicate a pathogenic role of T H 17-associated cytokines and T H 17 cells in inducing autoimmune tissue inflammation both in experimental animals and in humans.
Despite the recent major interest in T H 17 cells, these cells may not be the only T H cells that can induce autoimmunity because T H 1 cells can readily transfer organ-specific autoimmune disease 33 . It is therefore possible that there is a sequential involvement and different functions of T H 17 and T H 1 subsets rather than an exclusive role of these subsets during the development of autoimmune diseases and other tissue inflammation 34 . In this scenario, T H 17 cells might facilitate the migration of other T H cells (such as T H 1 cells) into the target tissue, which could further propagate and modulate inflammation and tissue damage.
Taken together, these data suggest that T H 17 cells are potent inducers of autoimmunity through the promotion of tissue inflammation and the mobilization of the innate immune system. However, in some tissues, such as the gut and perhaps the liver 35 , T H 17 cells, as potent early players of the adaptive immune system, might also have modulatory and protective roles.
At least two cytokines are needed to differentiate T H 17 cells
In contrast to T H 1 and T H 2 cell differentiation, which depend on their respective effector cytokines (IFN-c and IL-4) for differentiation, T H 17 differentiation does not require IL-17. Instead, IL-6 and TGFb-two cytokines with opposing effects-together induce the development of T H 17 cells 15, 36, 37 . IL-6 is a pro-inflammatory cytokine strongly induced in cells of the innate immune system on engagement 89 . IL-22R1 (CRF2-9) is expressed on a variety of epithelial and parenchymal tissues (skin, liver, kidney, pancreas, intestine and lung) 90 . Effects. IL-22 increases acute-phase reactants in hepatocytes 91 and protects them from acute liver inflammation 35 . It induces the expression of b-defensins in epithelial cells 6, 90 and promotes epidermal hyperplasia 9 . IL-21 Source. CD4
1 T cells stimulated with IL-6, T H 17 cells [10] [11] [12] , T follicular helper cells 13 , natural killer cells and natural killer T cells 10, 92 . Receptor(s). The receptor for IL-21 is a heterodimer consisting of common cytokine-receptor c chain (c c ) and IL-21R 93 . c c is expressed in lymphoid, but not in non-lymphoid and non-haematopoietic cells 94 . IL-21R is restricted to haematopoietic cells with highest levels of expression on B cells, but also on T cells, natural killer cells, and some populations of myeloid cells 92 . Effects. IL-21 participates in the differentiation/amplification of T H 17 cells [10] [11] [12] . In combination with IL-7 or IL-15, IL-21 stimulates the proliferation and differentiation of CD8 1 T cells 95, 96 . It promotes B-cell differentiation and antibody class switching (IgG1, IgG3) 96 , induces the differentiation and cytotoxic programme of natural killer cells 92 and natural killer T cells 97 , and induces CXCL8 in macrophages 98 .
of specific pattern-recognition receptors such as Toll-like receptors and C-type lectin receptors. Thus, infection or local inflammation induces large amounts of IL-6. In the immune system, TGF-b is regarded as an anti-inflammatory cytokine because the loss of TGFb is associated with a fatal lymphoproliferative disease 38 . In mice, TGF-b plus IL-6 have also been shown to be the differentiating factors for T H 17 cells in vivo. First, TGF-b transgenic animals immunized with the myelin oligodendrocyte glycoprotein MOG in complete Freund's adjuvant, which induces high amounts of IL-6, develop exacerbated EAE owing to enhanced frequencies of T H 17 cells 37 . Second, mice with a defect in TGF-b responsiveness in T cells are protected from EAE owing to the lack of generation of T H 17 cells 39 . Third, when TGF-b is not secreted by T cells as a result of a conditionally disrupted Tgfb gene in CD4 cells, T H 17 cells cannot be generated and the mice are relatively protected from developing EAE 40 . Consistent with the idea that T H 17 cells require both TGF-b and IL-6, we showed that IL-6-deficient mice fail to develop a T H 17 response and are resistant to the development of EAE 10, 37 . In humans, IL-17-producing T cells have been detected in the memory population of peripheral blood mononuclear cells (PBMCs); in one report they were characterized by the combined expression of CCR4 and CCR6 (ref. 41) , and in another they were characterized by the expression of CCR2 and lack of CCR5 (ref. 42) . A heterogeneous population of IL-17 and IFN-c double-producers resided in the CCR6
1 CXCR3 1 human memory-T-cell compartment 41 . It has been reported that in naive human T cells, the combination of TGF-b plus IL-6 or TGF-b plus IL-21 failed to induce the differentiation of T H 17 cells 43, 44 . Recent findings suggested that . When IL-6 is present, however, IL-21-receptor-deficient mice show a reduced but detectable T H 17 response in vitro and in vivo 10 . These findings point to a relevant function of IL-21, produced by newly generated T H 17 cells, in amplifying the precursor frequency of differentiating T H 17 cells (Fig. 2) . In addition to IL-21, other cytokines such as tumour-necrosis factor alpha (TNF-a) and IL-1, which are not specifically produced by T H 17 cells, have been proposed to have an additional role in the amplification of T H 17 responses 36, 47 .
What is the role of IL-23?
The observation that IL-23p19-deficient animals, which did not develop EAE, lack IL-17-producing T cells 24 and the fact that IL-23 could expand a population of IL-17-producing pathogenic cells Recently it has been shown that T cells cultured in the presence of TGF-b plus IL-6 did not induce tissue inflammation unless they are further cultured in the presence of IL-23, which could decrease the secretion of IL-10 by these cells 48, 49 . Although IL-23 was described eight years ago 50 , little is known about the role of IL-23 for T H 17 cells in vivo. IL-23 signals through a receptor composed of the IL-12Rb1 chain (which it shares with the IL-12 receptor) and a unique IL-23R subunit 51 . IL23R mRNA expression has mainly been detected in T cells, natural killer cells and natural killer T cells, but low levels of this receptor can also be found in monocytes, macrophages and dendritic cells 52 . Both IL-6 and IL-21 are strong inducers of IL-23R in T cells 12 . Furthermore, IL-23 can enhance the expression of its own receptor through an autocrine or paracrine feedback loop in mouse 3 (M. Oukka, unpublished observation) and human 45 T cells. The understanding of the regulation of IL-23R expression on naive T cells as they develop into T H 17 cells and on cells of the innate immune system will shed light on the role of this cytokine.
There is new evidence that IL-23 may have a profound impact on the innate immune system as well. Recent work has demonstrated that the development of gut inflammation in T-cell-deficient mice was dependent on IL-23, in that the loss of IL-23 but not IL-12 was associated with a decrease in gut inflammation mediated by anti-CD40-antibody-activated cells of the innate immune system 53 . IL-23 appears to induce IL-17, IL-1 and IL-6 from cells of the innate immune system 47, 53 . Whether IL-23-mediated gut inflammation is entirely dependent on IL-17 produced by cells of the innate immune system has not been addressed. Consistent with this finding, a genome-wide scan revealed that particular SNPs in the coding sequence (rs11209026, c.1142G . A, p.Arg381Gln) of the IL23R gene conferred strong protection from Crohn's disease 54 . It has not been tested whether the different IL-23R variants affect the innate or adaptive immune systems or both.
We propose that the full differentiation of T H 17 cells requires three different steps: induction, amplification and stabilization/maintenance (Fig. 2) . (1) The differentiation is initiated by the combined actions of IL-6 and TGF-b; (2) the amplification of the T H 17 response is driven through the production of IL-21 by T H 17 cells; (3) the stabilization/maintenance of the T H 17 phenotype is achieved by IL-23. Whereas the first two steps in the development of T H 17 cells seem to be distinct, it is possible that the stabilization and the amplification phases overlap or take place simultaneously.
T H 17-specific transcription factors
The differentiation of effector T H cells is initiated by proximal signals from the T-cell receptor, co-stimulatory molecules and cytokine receptors. These integrated signals then lead to the induction of lineage-specific transcription factors. T H 17 cells have emerged as a truly independent subset because their differentiation was shown to be independent of the T H 1-or T H 2-promoting transcription factors T-bet, STAT1, STAT4 and STAT6 (refs 55-57) . Consistent with the role of IL-6 in the differentiation of T H 17 cells, STAT3 appears to be critical for the differentiation of T H 17 cells because conditional deletion of STAT3 in T cells prevents the development of T H 17 cells 58 . Activation in the presence of TGF-b1 alone normally induces FOXP3 and generates induced T reg cells (iT reg cells). In T reg cells, the interaction of TGF-b1 with its receptor induces the phosphorylation of SMAD2/3 proteins and the formation of a complex with SMAD4, which then translocates to the nucleus. Whether similar molecules are involved in the differentiation of T H 17 cells remains to be determined.
Analogously to T H 1 and T H 2 subsets, T H 17 development relies on the action of a lineage-specific transcription factor, identified as the orphan nuclear receptor ROR-ct. ROR-ct is selectively expressed in T H 17 cells differentiated in the presence of TGF-b plus IL-6, and transduction of naive T cells with a retroviral vector containing ROR-ct induces the development of T H 17 cells 59 . Conversely, loss of ROR-ct in T cells prevents the generation of myelin-specific T H 17 cells and subsequently the development of EAE in mice immunized with myelin antigens. Furthermore, the analysis of ROR-ct-GFP (green fluorescent protein) reporter mice revealed the existence of a population of IL-17 1 cells that are constitutively present in the intestinal lamina propria and whose development depends on ROR-ct expression 59 . These observations argue in favour of a critical role of ROR-ct in the differentiation of the T H 17 lineage (Fig. 2) . However, the mechanisms by which ROR-ct drives T H 17 development have not yet been fully elucidated. A recent report indicates that, similarly to T-bet inducing IL-12Rb2, ROR-ct would induce IL-23R. More precisely, IL-6-mediated activation of both STAT3 and ROR-ct would promote the production of IL-21 by T H 17 cells, and IL-21 would then induce the expression of IL-23R and establish responsiveness of T H 17 cells to IL-23. In this model, a sequential involvement of IL-6, IL-21 and IL-23 would lead to the differentiation of T H 17 cells 12 . Another report suggested that the induction of IL-21 required STAT3, but not ROR-ct 11 . In addition, it has not yet been formally addressed whether ROR-ct directly transactivates the IL17A, IL17F, IL22 and IL21 genes in T H 17 cells. A more recent report suggested that T H 17 differentiation might be mediated by the combined effect of ROR-ct and ROR-a, both of which are expressed at high levels in differentiated T H 17 cells. Loss of only one of these transcription factors resulted in partial loss of T H 17 cytokine expression, and loss of both ROR-ct and ROR-a abrogated T H 17 differentiation 60 .
Reciprocal relationship between iT reg and T H 17 cells
TGF-b induces the T reg -specific transcription factor FOXP3 and is required for the maintenance of iT reg cells in the peripheral immune compartment. However, addition of IL-6 to TGF-b inhibits the generation of T reg cells and induces T H 17 cells. On the basis of these data, we first proposed 37 that there is a reciprocal relationship between T reg cells and T H 17 cells, and that IL-6 has a pivotal role in dictating the balance between these two cell populations 10, 37 .
This reciprocal relationship between T reg and T H 17 cells is further supported by recent data from other laboratories 61, 62 : IL-2, which is a growth factor for T reg cells, has also been shown to inhibit the generation of T H 17 cells 61 . Consistent with these data, mice that lack IL-2 or in which IL-2 signalling is compromised (Stat5
), harbour reduced numbers of T reg cells and an increased proportion of T H 17 cells in the peripheral repertoire 61 . Moreover, these mice develop multi-organ inflammatory diseases, which can be prevented by the passive transfer of T reg cells 63 . Additional evidence for a reciprocal developmental relationship between FOXP3
1 T reg cells and T H 17 cells came from the discovery that retinoic acid, a vitamin A metabolite, could drive the generation of T reg cells 64 by enhancing TGF-b signalling and enhancing FOXP3 promoter activity while abrogating the differentiation of T H 17 cells, but not of T H 1 cells, through the inhibition of IL-6 signalling 62 . These findings indicate that retinoic acid can regulate the balance between pro-inflammatory T H 17 cells and anti-inflammatory T reg cells (Fig. 3) .
Finally, it has been found that ROR-ct and RORa, the transcription factors for T H 17 cells, and FOXP3, the transcription factor for T reg cells, can physically bind to each other and antagonize each other's functions 65, 66 . In line with this concept, conditional deletion of FOXP3 protein in 'T reg cells' in vivo resulted in an increase in RORct, IL-17 and IL-21 expression 67, 68 , further corroborating the reciprocal relationship between T H 17 cells and T reg cells. response and enhanced inflammation of the central nervous system in two different disease models 70, 71 . Two recent studies showed that IL-27 together with TGF-b induces the differentiation of IL-10-producing T cells with Tr-1-like properties and that IL-27R-deficient mice (Wsx1
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) have a defect in generating IL-10-producing Tr-1 cells 48, 72 . Thus, IL-27 might also be necessary to control exaggerated immunopathology indirectly by inducing Tr-1 cells (Fig. 3) .
Role of TGF-b in inducing novel T H subsets
Since the discovery of TGF-b and IL-6 as the differentiation factors for T H 17 cells, we have proposed that the dual cytokine interaction (TGF-b plus a cytokine X) might be operational in the induction of other novel T-cell subsets as well. Tr-1 differentiation induced by a combination of TGF-b plus IL-27 supports this hypothesis 48, 72 . When TGF-b is involved in the differentiation of novel T H subsets, T H commitment might be accomplished either by TGF-b acting together with another cytokine, where the two cytokines will inhibit each other's functions and result in the generation of a totally new gene programme (for example, T H 17 differentiation induced by TGF-b plus IL-6), or by quantitatively scaling back each other's functions, thereby resulting in the production of only dominant cytokines in the responding T cells (for example, Tr-1 cells induced by TGF-b plus IL-27; Fig. 4 ). These observations suggest that T cells would sense multiple cytokine inputs simultaneously from the environment to initiate the differentiation of new T-cell subsets with distinct cytokine phenotypes and effector functions.
Concluding remarks
It is now established that T H 17 cells constitute an independent T-helper-cell subset with major functions in the induction of tissue inflammation and host protection against extracellular pathogens. Since their initial description, substantial progress has been made in the understanding of T H 17 differentiation and effector functions. On the basis of recent reports, we propose a three-step model for the 
